PubRank

Sven Hillinger

Author PubWeight™ 37.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term outcomes of bilateral lobar lung transplantation. Eur J Cardiothorac Surg 2012 2.76
2 Thoracoscopic treatment of pulmonary sequestration. Eur J Cardiothorac Surg 2006 2.09
3 Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer. J Thorac Cardiovasc Surg 2010 1.71
4 Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapy. Eur J Cardiothorac Surg 2012 1.65
5 Sildenafil extends survival and graft function in a large animal lung transplantation model. Eur J Cardiothorac Surg 2006 1.39
6 Surfactant improves graft function after gastric acid-induced lung damage in lung transplantation. Ann Thorac Surg 2012 1.39
7 A mouse model of orthotopic, single-lung transplantation. J Thorac Cardiovasc Surg 2009 1.18
8 Intrapulmonary administration of CCL21 gene-modified dendritic cells reduces tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Cancer Res 2006 1.12
9 SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10. Mol Cancer 2003 1.11
10 Intratumoral administration of dendritic cells overexpressing CCL21 generates systemic antitumor responses and confers tumor immunity. Clin Cancer Res 2004 1.09
11 Human monoclonal antibodies to domain C of tenascin-C selectively target solid tumors in vivo. Protein Eng Des Sel 2006 0.98
12 Airway complications after lung transplantation: risk factors, prevention and outcome. Eur J Cardiothorac Surg 2008 0.97
13 Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses. J Immunol 2005 0.91
14 Interleukin-7 gene-modified dendritic cells reduce pulmonary tumor burden in spontaneous murine bronchoalveolar cell carcinoma. Hum Gene Ther 2003 0.88
15 Fibrinolytic treatment improves the quality of lungs retrieved from non-heart-beating donors. J Heart Lung Transplant 2007 0.86
16 Local recurrence model of malignant pleural mesothelioma for investigation of intrapleural treatment. Eur J Cardiothorac Surg 2007 0.86
17 Ex vivo reconditioning of marginal donor lungs injured by acid aspiration. J Heart Lung Transplant 2008 0.86
18 Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage. Lung Cancer 2012 0.86
19 Comparative immunohistochemistry of L19 and F16 in non-small cell lung cancer and mesothelioma: two human antibodies investigated in clinical trials in patients with cancer. Lung Cancer 2008 0.86
20 Outcome of Extracorporeal Membrane Oxygenation as a Bridge To Lung Transplantation: An Institutional Experience and Literature Review. Transplantation 2015 0.86
21 Simplified rat lung transplantation by using a modified cuff technique. J Invest Surg 2008 0.85
22 The effect of perfluorocarbon-based artificial oxygen carriers on tissue-engineered trachea. Tissue Eng Part A 2009 0.83
23 Extended donor lungs: eleven years experience in a consecutive series. Eur J Cardiothorac Surg 2005 0.83
24 Primary graft dysfunction in lung transplantation: the role of CD26/dipeptidylpeptidase IV and vasoactive intestinal peptide. Transplantation 2009 0.82
25 N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg 2007 0.82
26 CD26/dipeptidylpeptidase IV-targeted therapy of acute lung rejection in rats. J Heart Lung Transplant 2006 0.82
27 Accelerated angiogenesis by continuous medium flow with vascular endothelial growth factor inside tissue-engineered trachea. Eur J Cardiothorac Surg 2007 0.80
28 Prevention of primary graft dysfunction in lung transplantation by N-acetylcysteine after prolonged cold ischemia. J Heart Lung Transplant 2010 0.80
29 The effect of organ-specific CD26/DPP IV enzymatic activity inhibitor-preconditioning on acute pulmonary allograft rejection. Transplantation 2009 0.80
30 Persistent benefit from lung volume reduction surgery in patients with homogeneous emphysema. Ann Thorac Surg 2009 0.80
31 Laser-capture microdissection impairs activity-based protein profiles for serine hydrolase in human lung adenocarcinoma. J Biomol Tech 2010 0.78
32 Intragraft DPP IV inhibition attenuates post-transplant pulmonary ischemia/reperfusion injury after extended ischemia. J Heart Lung Transplant 2007 0.78
33 Intra-scaffold continuous medium flow combines chondrocyte seeding and culture systems for tissue engineered trachea construction. Interact Cardiovasc Thorac Surg 2008 0.77
34 Acute allograft rejection and immunosuppression: influence on endogenous melatonin secretion. J Pineal Res 2008 0.77
35 KRAS mutation is associated with elevated myeloblastin activity in human lung adenocarcinoma. Cancer Genomics Proteomics 2012 0.76
36 Simultaneous bilateral lobar lung transplantation: one donor serves two recipients. Ann Thorac Surg 2013 0.76
37 Minimally invasive resection of thymomas with the da Vinci® Surgical System. Eur J Cardiothorac Surg 2012 0.76
38 Reconditioning of an injured lung graft with intrabronchial surfactant instillation in an ex vivo lung perfusion system followed by transplantation. J Surg Res 2013 0.75
39 Impact of topical cooling solution and prediction of pulmonary graft viability from non-heart-beating donors. J Heart Lung Transplant 2008 0.75
40 Distribution of macrophages and T cells in syngrafts and allografts after experimental rat lung transplantation. Immunobiology 2009 0.75
41 The role of CD26/DPP IV in preservation of early pulmonary graft function. Adv Exp Med Biol 2006 0.75
42 Trachea reconstruction using novel tissue engineered constructs. Swiss Med Wkly 2007 0.75
43 [Tumor surveillance after resection of lung cancer]. Ther Umsch 2008 0.75